United Therapeutics (NASDAQ:UTHR) Cut to Buy at StockNews.com
StockNews.com lowered shares of United Therapeutics (NASDAQ:UTHR – Free Report) from a strong-buy rating to a buy rating in a report published on Thursday. UTHR has been the topic of a number of other reports. Oppenheimer boosted their price target on shares of United Therapeutics from $575.00 to $600.00 and gave the stock an “outperform” […]
StockNews.com lowered shares of United Therapeutics (NASDAQ:UTHR – Free Report) from a strong-buy rating to a buy rating in a report published on Thursday. UTHR has been the topic of a number of other reports. Oppenheimer boosted their price target on shares of United Therapeutics from $575.00 to $600.00 and gave the stock an “outperform” […]
